Good news (or is it?): The average U.S. Food and Drug Administration drug review time is at its lowest point this century. A handy chart from the California Healthcare Institute and Boston Consulting Group released today at BIO 2014 in San Diego highlights the precipitous drop in the time of review and approval of drugs. […]
Uber is changing the way we catch a cab by eliminating the hack license and a taxi company. The passenger clicks, asks and someone drives up. What if drug researchers could remove a middleman in the same way? Imagine they call out, Uber style, for help developing one of their nascent medical treatments? Then, a […]
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Supporters say changing Small Business Innovation Research rules to give venture capitalists (and their companies) access to more government funds will accelerate a national economic resurgence. Plus, they point out that many venture companies are small operations far from the perception of a nine-figure equity fund. But other small businesses, include life-science companies, see the changes as a potential death knell to small business funding and the spirit of innovation.
A report authored by Battelle shows that American students are focused enough on biotech and other sciences. But wWhat's illuminating, though, is how much has been tried to increase interest in science, the evidence of what is going right, what's worth scrapping and what's worth paying for.